Investigation of Acorda Therapeutics, Inc. by Securities Lawyers at Goldfarb LLP Law Firm for Potential Shareholder Claim – Yahoo Finance
DALLAS, June 5, 2012 /PRNewswire/ -- Goldfarb LLP is investigating whether the board of directors of Acorda Therapeutics, Inc. (ACOR) violated shareholder protection laws by allegedly breaching compliance matters concerning adverse drug ...
Subscribe to LegalLaw247.Com Newsletter